ANOS1 rs121908011: Understanding X-Linked Kallmann Syndrome
The ANOS1 variant rs121908011 is a genetic alteration associated with X-linked Kallmann syndrome, a condition characterized by delayed or absent puberty and an impaired sense of smell. This variant affects the function of the ANOS1 gene, which is critical for the proper migration of neurons responsible for reproductive hormone regulation.
What each genotype means
Typical ANOS1 function
This genotype represents the common, functional version of the ANOS1 gene. Individuals with this profile do not carry the specific loss-of-function mutation associated with X-linked Kallmann syndrome at this locus.
This is the most common genotype found in the general population.
Potential pathogenic variant carrier
This genotype indicates the presence of a variant allele in the ANOS1 gene. Because ANOS1 is located on the X chromosome, males with this variant are typically affected by the associated condition, while females may be carriers; please consult a genetic counselor or clinician to understand the specific clinical implications of this variant.
This genotype is extremely rare in the general population.
Pathogenic variant present
This genotype indicates the presence of the variant allele on the X chromosome. In the context of ANOS1, such variants are associated with deficient GnRH neuronal migration and failure to undergo spontaneous puberty, characteristic of X-linked Kallmann syndrome. Please discuss these findings with a medical professional for clinical context and appropriate management.
This genotype is extremely rare and is primarily identified in clinical settings involving individuals with hypogonadotropic hypogonadism.
What is the rs121908011 Variant?
The rs121908011 variant refers to a specific change within the ANOS1 gene, located on the X chromosome. In genetics, an rsID (reference SNP cluster ID) is a unique label used by researchers to track specific locations in the human genome where variations occur. Because ANOS1 is located on the X chromosome, the inheritance pattern of variants in this gene is X-linked. This means that the clinical impact of the variant differs significantly between males and females. In males, who possess only one X chromosome, a single copy of a pathogenic variant is sufficient to disrupt normal gene function. In females, who have two X chromosomes, the presence of a second, functional copy of the gene often compensates for the variant, typically resulting in a carrier status rather than the full clinical presentation of the associated syndrome.
The Role of the ANOS1 Gene
The ANOS1 gene provides instructions for producing a protein called anosmin-1. This protein acts as a signaling molecule that plays a vital role during embryonic development. Specifically, anosmin-1 is essential for the migration of gonadotropin-releasing hormone (GnRH) neurons from the nose to the hypothalamus in the brain. These neurons are the master regulators of the reproductive system, as they trigger the release of hormones necessary for sexual development and puberty. Additionally, anosmin-1 is involved in the development of the olfactory bulb, which is the part of the brain responsible for the sense of smell. When the ANOS1 gene is mutated, the production or function of anosmin-1 is compromised, which prevents GnRH neurons from reaching their destination and disrupts the development of the olfactory system.
Research and Clinical Associations
Scientific research has firmly established that loss-of-function mutations in the ANOS1 gene are a primary cause of X-linked Kallmann syndrome. Clinical evidence indicates that individuals with pathogenic variants in this gene often present with congenital hypogonadotropic hypogonadism, a condition where the body fails to produce enough sex hormones, leading to a failure to undergo spontaneous puberty. This is frequently accompanied by anosmia or hyposmia, which is the total or partial loss of the sense of smell. The evidence strength for the association between ANOS1 dysfunction and these clinical features is considered moderate to high in the context of clinical genetics. Researchers continue to study how specific missense or truncating mutations alter the protein's structure, as these variations can lead to a spectrum of clinical severity in affected individuals.
Population Frequency and Inheritance
The rs121908011 variant is classified as extremely rare in the general population. Because it is an X-linked condition, it is most frequently identified in males who present with symptoms of Kallmann syndrome. In many cases, the mutation is inherited from a mother who carries the variant on one of her X chromosomes but does not exhibit symptoms herself. In other instances, the variant may arise as a de novo (new) mutation in the affected individual. Due to its rarity, large-scale population studies often show very low allele frequencies, making it a variant that is primarily identified through clinical diagnostic testing for individuals presenting with specific reproductive or olfactory developmental delays.
Navigating Genetic Information
Understanding a genetic variant like rs121908011 is a complex process that should always be conducted in consultation with a healthcare professional, such as a genetic counselor or an endocrinologist. Genetic information is not a diagnosis in itself; it is a piece of data that must be interpreted within the context of an individual's clinical history, physical examination, and hormone testing. If you or a family member have concerns about puberty, reproductive health, or the sense of smell, it is important to seek a clinical evaluation. A medical professional can determine if genetic testing is appropriate and help explain what the results mean for your health. Never use genetic data to make independent medical decisions or to self-diagnose, as clinical management requires specialized care and oversight.
How common is this variant?
The rs121908011 variant is extremely rare in the general population, with its occurrence primarily documented in clinical cases of X-linked Kallmann syndrome.
Frequently asked questions
What is Kallmann syndrome?
Kallmann syndrome is a genetic condition characterized by the combination of delayed or absent puberty and an impaired or absent sense of smell. It is caused by the failure of specific neurons to migrate correctly during brain development.
Can females have Kallmann syndrome caused by ANOS1?
While ANOS1-related Kallmann syndrome is X-linked, it is extremely rare for females to be affected. Because females have two X chromosomes, they typically require mutations in both copies to show symptoms, which is statistically very unlikely.
Is there a cure for ANOS1-related conditions?
There is no cure for the underlying genetic mutation, but the symptoms of hypogonadotropic hypogonadism are often managed with hormone replacement therapy. This treatment can help induce puberty and maintain secondary sexual characteristics.
How is this variant diagnosed?
Diagnosis typically involves a combination of clinical assessment by an endocrinologist, hormone level testing, and genetic sequencing of the ANOS1 gene. Genetic testing is usually performed in a clinical laboratory setting.
Should I get tested for this variant?
Genetic testing is generally recommended only if you have clinical symptoms or a family history of Kallmann syndrome. You should discuss the necessity and implications of testing with a genetic counselor or your primary care physician.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908011?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29